TOP LINK ALTERNATIF MBL77 SECRETS

Not all individuals with CLL require therapy. In spite of all new advances, the iwCLL nevertheless suggests watchful observation for patients with asymptomatic disease.86 This suggestion is predicated on no less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).MP